BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
70 results:

  • 1. CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma.
    Nishida H; Kondo Y; Kusaba T; Kawamura K; Oyama Y; Daa T
    PLoS One; 2023; 18(2):e0281647. PubMed ID: 36780540
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis.
    Thao V; Dholakia R; Moriarty JP; Borah BJ; Dwarkasing J; Meves A
    Int J Dermatol; 2023 Jan; 62(1):56-61. PubMed ID: 36440797
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
    Goto K; Pissaloux D; Tirode F; de la Fouchardière A
    J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigation of Genetic Mutations in High-risk and Low-risk Basal Cell Carcinoma in a Non-Caucasian Population by Whole Exome Sequencing.
    Kim HJ; Lee M; Lee YB; Yu DS
    Acta Derm Venereol; 2021 May; 101(5):adv00458. PubMed ID: 33928395
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
    Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
    Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and application of high-throughput screens for the discovery of compounds that disrupt erbb4 signaling: Candidate cancer therapeutics.
    Cullum RL; Lucas LM; Senfeld JI; Piazza JT; Neel LT; Whig K; Zhai L; Harris MH; Rael CC; Taylor DC; Cook LJ; Kaufmann DP; Mill CP; Jacobi MA; Smith FT; Suto M; Bostwick R; Gupta RB; David AE; Riese Ii DJ
    PLoS One; 2020; 15(12):e0243901. PubMed ID: 33378376
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Robot-assisted Nipple-sparing Mastectomy With Immediate Breast Reconstruction: An initial Experience of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).
    Ryu JM; Kim JY; Choi HJ; Ko B; Kim J; Cho J; Lee MH; Choi JE; Kim JH; Lee J; Jung SM; Shin HJ; Lee J; Park HS
    Ann Surg; 2022 May; 275(5):985-991. PubMed ID: 32941285
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil.
    Castellucci LC; Almeida L; Cherlin S; Fakiola M; Francis RW; Carvalho EM; Santos da Hora A; do Lago TS; Figueiredo AB; Cavalcanti CM; Alves NS; Morais KLP; Teixeira-Carvalho A; Dutra WO; Gollob KJ; Cordell HJ; Blackwell JM
    Clin Infect Dis; 2021 May; 72(10):e515-e525. PubMed ID: 32830257
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
    Lobl MB; Clarey D; Higgins S; Sutton A; Hansen L; Wysong A
    J Dermatol Sci; 2020 Jul; 99(1):30-43. PubMed ID: 32595073
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Patterns of Metastasis in Merkel Cell Carcinoma.
    Song Y; Azari FS; Tang R; Shannon AB; Miura JT; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2021 Jan; 28(1):519-529. PubMed ID: 32405979
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
    Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
    J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
    Hoesl C; Fröhlich T; Hundt JE; Kneitz H; Goebeler M; Wolf R; Schneider MR; Dahlhoff M
    Mol Oncol; 2019 Nov; 13(11):2476-2492. PubMed ID: 31580518
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
    BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Negative feedback regulation of erbb4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation.
    Haryuni RD; Watabe S; Yamaguchi A; Fukushi Y; Tanaka T; Kawasaki Y; Zhou Y; Yokoyama S; Sakurai H
    Biochem Biophys Res Commun; 2019 Jun; 514(2):456-461. PubMed ID: 31053301
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
    Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
    Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Challenges in next generation sequencing analysis of somatic mutations in transplant patients.
    Chen H; Luthra R; Patel KP; Routbort M; Rashid A; Roy-Chowdhuri S; Lazar A; Broaddus R; Manekia J; Singh RR; Yemelyanova A
    Cancer Genet; 2018 Oct; 226-227():17-22. PubMed ID: 30005850
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
    Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
    Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.